Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 5, 1996, Pages 1071-1078

  Rose, Gail ^a   Arlian, Larry ^b   Bernstein, David ^c   Grant, Andrew ^d   Lopez, Manuel ^e   Metzger, James ^f   Wasserman, Stephen ^g   Platts Mills, Thomas A E ^a  

^a UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EAST CAROLINA UNIVERSITY   (United States)

^g UCSD MEDICAL CENTER   (United States)

Author keywords

asthma; dust mites; exposure; Immunotherapy; sensitization; skin testing

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOUSE DUST; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIZATION; SKIN TEST;

EID: 0030004729     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70260-9     Document Type: Article

References (32)

1. CIBA Foundation Guest Symposium. Terminology, definitions, and classifications of chronic pulmonary emphysema and related conditions. Thorax 1959;14:286-99.
2. American Thoracic Society. Chronic bronchitis, asthma, and pulmonary emphyma. Am Rev Respir Dis 1987;136:224-5.
3. Busse W, Reed C. Asthma: definition and pathogenesis. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. St. Louis: Mosby, 1993:1173-201.
4. Lau S, Falkenhorst G, Weber A, et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol 1989;84:718-25.
5. Pollart S, Chapman M, Fiocco G, Rose G, Platts-Mills T. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 1989;83:875-82.
6. Call R, Smith T, Morris E, Chapman M, Platts-Mills T. Risk factors for asthma in inner city children. J Pediatr 1992;121:862-6.
7. Sporik R, Holgate S, Platts-Mills T, Cogswell J. Exposure to house-dust mite allergen (Dor p I) and the development of asthma in childhood: a prospective study. N Engl J Med 1990;323:502-7.
8. Gelber LE, Seltzer LH, Bouzoukis JK, Pollart SM, Chapman MD, Platts-Mills TAE. Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital. Am Rev Respir Dis 1993;147:573-8.
9. Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma: a world-wide problem. J Allergy Clin Immunol 1989;83:416-27.
10. Noon L. Prophylactic inoculation against hayfever. Lancet 1911;1:1572-3.
11. Freeman J. Further observations on the treatment of hayfever by hypodermic inoculations of pollen vaccine. Lancet 1911;2:814-7.
12. Spain WC, Cooke RA. Studies in specific hypersensitivity. II. The familial incidence of hayfever and bronchial asthma. J Immunol 1924;9:521-9.
13. Ohman J. Allergen immunotherapy in asthma: evidence for efficacy. J Allergy Clin Immunol 1989;84:133-40.
14. Norman PS. Immunotherapy for nasal allergy. J Allergy Clin Immunol 1988;81:992-6.
15. Bousquet J, Michel F. Specific immunotherapy in asthma: Is it effective? J Allergy Clin Immunol 1994;94:1-11.
16. Arlian LG, Bernstein D, Bernstein IL, et al. Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol 1992;90:292-300.
17. Luczynska C, Arruda L, Platts-Mills T, Miller J, Lopez M, Chapman M. A two-site monoclonal antibody ELISA for the quantitation of the major Dermatophagoides ssp. allergens, Der pI and Der fI. J Immunol Methods 1989;118:227-35.
18. Ford AW, Rawle FC, Lind P, Spieksman FthM, Lowestein H, Platts-Mills TAE. Standardization of Dermatophagoides pteronyssinus: assessment of potency and allergen content in ten coded extracts. Int Arch Allergy Appl Immunol 1985;76:58-67.
19. Hassner A, Saxon A. Inhibition of ongoing myeloma IgE synthesis in vitro by activated human T cells. J Immunol 1983;130:1567-72.
20. Chapman MD, Platts-Mills TAE, Gabriel M, et al. Antibody responses following prolonged hyposensitization with Dermatophagoides pteronyssinus extract. Int Arch Allergy Appl Immunol 1980;61:431-40.
21. 1. J Immunol 1980;125:587-92.
22. Arlian LG, Bernstein IL, Gallagher JS. The prevalence of house dust mites, Dermatophagoides spp., and associated environmental conditions in homes in Ohio. J Allergy Clin Immunol 1982;60:527-32.
23. Pollart SM, Smith TF, Morris EC, Gelber LE, Platts-Mills TAE, Chapman MD. Environmental exposure to cockroach allergens: analysis with monoclonal antibody-based enzyme immunoassays. J Allergy Clin Immunol 1991;87:505-10.
24. Luczynska CM, Li Y, Chapman MD, Platts-Mills TAE. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus): measurements using cascade impactor, liquid impinger, and a two site monoclonal antibody assay for Fei d1. Am Rev Respir Dis 1990;141:361-7.
25. Platts-Mills TAE, Thomas WR, Aalberse RC, Vervloel D, Chapman MD. Dust mite allergens and asthma: report of a second international workshop. J Allergy Clin Immunol 1992;89:1046-60.
26. Arruda LK, Rizzo MC, Chapman MD, et al. Exposure and sensitization to dust mite allergens among asthmatic children in Sao Paulo, Brazil. Clin Exp Allergy 1991;21:433-9.
27. Wood RA, Eggleston PA, Mudd Ke, Adkinson NF Jr. Indoor allergen levels as a risk factor for allergic sensitization [Abstract]. J Allergy Clin Immunol 1989;83:1:199.
28. Peat JK, Britton WJ, Salome CM, Woolcock AJ. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. III. Effects of exposure to environmental allergens. Clin Allergy 1987;17:297-300.
29. Murray AB, Ferguson AC. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics 1983;71:418-22.
30. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hypersensitivity in sensitive children with asthma. J Allergy Clin Immunol 1992;90:135-8.
31. Boner AL, Niero E, Antolini I, Valletta EA, Gaburro D. Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in the Italian Alps (Misurina 1756m). Ann Allergy 1985;54:42-5.
32. Platts-Mills TAE, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982;2:675-8.